Baclofen for Children With Rumination Syndrome

Completed · Phase 3 · Has a placebo group

Conditions studied: Rumination Syndrome

In brief

The goal of this clinical trial is to learn about baclofen in pediatric patients with rumination syndrome. The main question it aims to answer is whether baclofen is effective in treating children with rumination syndrome. Participants will be asked to take baclofen or placebo for 4 weeks and fill out surveys regarding symptoms.

Key facts

Study ID

NCT05975684

Run by

Nationwide Children's Hospital

People needed

50

Starts

2023-01-31

Expected to finish

2025-01-27

Last updated by the study team

2026-03-06

Who can join

Age: 4 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Children 4-18 years of age who meets Rome IV diagnostic criteria for rumination syndrome and are see at NCH GI clinic

You may not qualify if…

• Patients who have contraindications to baclofen due to medical history and/or current medications
• Patients who are non- English speaking
• Patients who are pregnant

Where it is running

• Nationwide Children's Hospital — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.